Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Cardiomyogenesis in the aging and failing human heart.

Kajstura J, Rota M, Cappetta D, Ogórek B, Arranto C, Bai Y, Ferreira-Martins J, Signore S, Sanada F, Matsuda A, Kostyla J, Caballero MV, Fiorini C, D'Alessandro DA, Michler RE, del Monte F, Hosoda T, Perrella MA, Leri A, Buchholz BA, Loscalzo J, Anversa P.

Circulation. 2012 Oct 9;126(15):1869-81. doi: 10.1161/CIRCULATIONAHA.112.118380. Epub 2012 Sep 6. Retraction in: Circulation. 2014 Apr 22;129(16):e466.

2.

Myocyte turnover in the aging human heart.

Kajstura J, Gurusamy N, Ogórek B, Goichberg P, Clavo-Rondon C, Hosoda T, D'Amario D, Bardelli S, Beltrami AP, Cesselli D, Bussani R, del Monte F, Quaini F, Rota M, Beltrami CA, Buchholz BA, Leri A, Anversa P.

Circ Res. 2010 Nov 26;107(11):1374-86. doi: 10.1161/CIRCRESAHA.110.231498. Epub 2010 Nov 18.

3.

Cardiomyogenesis in the adult human heart.

Kajstura J, Urbanek K, Perl S, Hosoda T, Zheng H, Ogórek B, Ferreira-Martins J, Goichberg P, Rondon-Clavo C, Sanada F, D'Amario D, Rota M, Del Monte F, Orlic D, Tisdale J, Leri A, Anversa P.

Circ Res. 2010 Jul 23;107(2):305-15. doi: 10.1161/CIRCRESAHA.110.223024. Epub 2010 Jun 3.

4.

[Molecular mechanisms of cardiomyogenesis and perspectives of cardiomyocyte regeneration in cardiac failure].

Shirinskiĭ VP, Khapchaev AIu, Stepanova OV.

Mol Biol (Mosk). 2008 Sep-Oct;42(5):856-66. Review. Russian.

PMID:
18988534
5.

Isolated ventricular myocytes from failing and non-failing human heart; the relation of age and clinical status of patients to isoproterenol response.

Harding SE, Jones SM, O'Gara P, del Monte F, Vescovo G, Poole-Wilson PA.

J Mol Cell Cardiol. 1992 May;24(5):549-64.

PMID:
1321914
6.

The cardiovascular unit as a dynamic player in disease and regeneration.

Ausoni S, Sartore S.

Trends Mol Med. 2009 Dec;15(12):543-52. doi: 10.1016/j.molmed.2009.10.002. Epub 2009 Nov 11.

PMID:
19913457
7.

Human heart failure: is cell therapy a valid option?

Rota M, Leri A, Anversa P.

Biochem Pharmacol. 2014 Mar 15;88(2):129-38. doi: 10.1016/j.bcp.2013.10.031. Epub 2013 Nov 13. Review.

8.

Mechanisms of myocardial regeneration.

Leri A, Kajstura J, Anversa P.

Trends Cardiovasc Med. 2011 Feb;21(2):52-8. doi: 10.1016/j.tcm.2012.02.006. Review.

9.

Innate regeneration in the aging heart: healing from within.

Anversa P, Leri A.

Mayo Clin Proc. 2013 Aug;88(8):871-83. doi: 10.1016/j.mayocp.2013.04.001.

10.

Increased cardiac myocyte progenitors in failing human hearts.

Kubo H, Jaleel N, Kumarapeli A, Berretta RM, Bratinov G, Shan X, Wang H, Houser SR, Margulies KB.

Circulation. 2008 Aug 5;118(6):649-57. doi: 10.1161/CIRCULATIONAHA.107.761031. Epub 2008 Jul 21.

11.

Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart.

Urbanek K, Cabral-da-Silva MC, Ide-Iwata N, Maestroni S, Delucchi F, Zheng H, Ferreira-Martins J, Ogórek B, D'Amario D, Bauer M, Zerbini G, Rota M, Hosoda T, Liao R, Anversa P, Kajstura J, Leri A.

Circ Res. 2010 Aug 6;107(3):429-41. doi: 10.1161/CIRCRESAHA.110.218487. Epub 2010 Jun 17.

12.
13.

Aging Effects on Cardiac Progenitor Cell Physiology.

Rota M, Goichberg P, Anversa P, Leri A.

Compr Physiol. 2015 Sep 20;5(4):1775-814. doi: 10.1002/cphy.c140082. Review.

PMID:
26426466
14.

Stem cell therapy in the aging hearts of Fisher 344 rats: synergistic effects on myogenesis and angiogenesis.

Min JY, Chen Y, Malek S, Meissner A, Xiang M, Ke Q, Feng X, Nakayama M, Kaplan E, Morgan JP.

J Thorac Cardiovasc Surg. 2005 Aug;130(2):547-53.

15.

Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration.

Narmoneva DA, Vukmirovic R, Davis ME, Kamm RD, Lee RT.

Circulation. 2004 Aug 24;110(8):962-8. Epub 2004 Aug 9.

16.

Myocyte growth in the failing heart.

Kajstura J, Leri A, Castaldo C, Nadal-Ginard B, Anversa P.

Surg Clin North Am. 2004 Feb;84(1):161-77. Review.

PMID:
15053188
17.

Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology.

Leri A, Kajstura J, Anversa P.

Circ Res. 2011 Sep 30;109(8):941-61. doi: 10.1161/CIRCRESAHA.111.243154. Review.

18.

Aging, cardiac hypertrophy and ischemic cardiomyopathy do not affect the proportion of mononucleated and multinucleated myocytes in the human heart.

Olivetti G, Cigola E, Maestri R, Corradi D, Lagrasta C, Gambert SR, Anversa P.

J Mol Cell Cardiol. 1996 Jul;28(7):1463-77.

PMID:
8841934
19.

HMGB1 attenuates cardiac remodelling in the failing heart via enhanced cardiac regeneration and miR-206-mediated inhibition of TIMP-3.

Limana F, Esposito G, D'Arcangelo D, Di Carlo A, Romani S, Melillo G, Mangoni A, Bertolami C, Pompilio G, Germani A, Capogrossi MC.

PLoS One. 2011;6(6):e19845. doi: 10.1371/journal.pone.0019845. Epub 2011 Jun 22.

20.

Hemodynamic support by left ventricular assist devices reduces cardiomyocyte DNA content in the failing human heart.

Wohlschlaeger J, Levkau B, Brockhoff G, Schmitz KJ, von Winterfeld M, Takeda A, Takeda N, Stypmann J, Vahlhaus C, Schmid C, Pomjanski N, Böcking A, Baba HA.

Circulation. 2010 Mar 2;121(8):989-96. doi: 10.1161/CIRCULATIONAHA.108.808071. Epub 2010 Feb 16.

Supplemental Content

Support Center